Benchmark dose analyses of multiple genetic toxicity endpoints permit robust, cross-tissue comparisons of MutaMouse responses to orally delivered benzo[a]pyrene.

Benchmark dose analyses of multiple genetic toxicity endpoints permit robust, cross-tissue comparisons of MutaMouse responses to orally delivered benzo[a]pyrene.
复制标题

DOI:
10.1007/s00204-017-2099-2
复制
发表时间:
2018-03
影响因子:
6.1
通讯作者:
White PA
White PA
中科院分区:
医学2区
文献类型:
--
作者:
Long AS;Wills JW;Krolak D;Guo M;Dertinger SD;Arlt VM;White PA

文献摘要

参考文献

被引文献

相似文献

Genetic damage is a key event in tumorigenesis, and chemically induced genotoxic effects are a human health concern. Although genetic toxicity data have historically been interpreted using a qualitative screen-and-bin approach, there is increasing interest in quantitative analysis of genetic toxicity dose–response data. We demonstrate an emerging use of the benchmark dose (BMD)-approach for empirically ranking cross-tissue sensitivity. Using a model environmental carcinogen, we quantitatively examined responses for four genetic damage endpoints over an extended dose range, and conducted cross-tissue sensitivity rankings using BMD100 values and their 90% confidence intervals (CIs). MutaMouse specimens were orally exposed to 11 doses of benzo[a]pyrene. DNA adduct frequency and lacZ mutant frequency (MF) were measured in up to 8 tissues, and Pig-a MF and micronuclei (MN) were assessed in immature (RETs) and mature red blood cells (RBCs). The cross-tissue BMD pattern for lacZ MF is similar to that observed for DNA adducts, and is consistent with an oral route-of-exposure and differences in tissue-specific metabolism and proliferation. The lacZ MF BMDs were significantly correlated with the tissue-matched adduct BMDs, demonstrating a consistent adduct conversion rate across tissues. The BMD CIs, for both the Pig-a and the MN endpoints, overlapped for RETs and RBCs, suggesting comparable utility of both cell populations for protracted exposures. Examination of endpoint-specific response maxima illustrates the difficulty of comparing BMD values for a fixed benchmark response across endpoints. Overall, the BMD-approach permitted robust comparisons of responses across tissues/endpoints, which is valuable to our mechanistic understanding of how benzo[a]pyrene induces genetic damage. The online version of this article (doi:10.1007/s00204-017-2099-2) contains supplementary material, which is available to authorized users.
DOI: 10.1093/carcin/10.4.673
发表时间: 1989-04-01
期刊: CARCINOGENESIS
影响因子: 4.7
作者:
GINSBERG, GL;ATHERHOLT, TB
通讯作者: ATHERHOLT, TB
DOI: 10.1093/nar/20.12.3254
发表时间: 1992-06-25
影响因子: 14.9
作者:
GOSSEN, JA;MOLIJN, AC;VIJG, J
通讯作者: VIJG, J
DOI: 10.1073/pnas.86.20.7971
发表时间: 1989-10-01
影响因子: 11.1
作者:
GOSSEN, JA;DELEEUW, WJF;VIJG, J
通讯作者: VIJG, J
DOI: 10.1016/s0003-9861(03)00174-7
发表时间: 2003-06-01
影响因子: 3.9
作者:
Choudhary, D;Jansson, I;Stoilov, I
通讯作者: Stoilov, I
DOI: 10.2903/j.efsa.2009.1150
发表时间: 2009-06-01
期刊: EFSA JOURNAL
影响因子: 3.3
作者:
Barlow, Susan;Chesson, Andrew;Vannier, Philippe
通讯作者: Vannier, Philippe